Getinge AB Announces Successful Completion of Cash Tender Offer for Datascope Corp.

Getinge AB Announces Successful Completion of  Cash Tender Offer for Datascope
Corp. 

January 30, 2009

Getinge AB (STO: GETIB) (“Getinge”) announced today the successful completion of
its tender offer to acquire all outstanding shares of common stock of Datascope
Corp. (NASDAQ: DSCP) (“Datascope”), at a price of $53.00 per share in cash. 

The initial offering period for the tender offer expired at 12:00 midnight, New
York City time, at the end of Thursday, January 29, 2009, at which time
approximately 96% of the outstanding shares of Datascope common stock had been
validly tendered and not withdrawn.  All shares that were validly tendered and
not withdrawn have been accepted for purchase in accordance with the terms of
the offer. 

Immediately following its acceptance of the tendered shares, Getinge acquired
all of the remaining Datascope shares by means of a short-form merger under
Delaware law at the same price per share paid in the tender offer. Upon
completion of the merger, Datascope became an indirect wholly owned subsidiary
of Getinge and will no longer be traded on the NASDAQ. 


About Getinge AB
Getinge is a leading global provider of equipment and systems that contribute to
quality enhancement and cost efficiency within healthcare and life sciences. 
Equipment, service and technologies are supplied under the brands ArjoHuntleigh
for patient handling and hygiene, disinfection, DVT prevention, medical beds,
therapeutic surfaces and diagnostics, GETINGE for infection control and
prevention within healthcare and life science and MAQUET for surgical
workplaces, cardiopulmonary and critical care.  For news releases, webcasts and
other information about Getinge, please visit Getinge's website,
http://www.getingegroup.com.

About Datascope Corp.
Datascope is the global leader of intra-aortic balloon counterpulsation and a
diversified medical device company that develops, manufactures and markets
proprietary products for clinical health care markets in interventional
cardiology, cardiovascular and vascular surgery and critical care. The Company's
products are sold throughout the world through direct sales representatives and
independent distributors. Founded in 1964, Datascope is headquartered in
Montvale, New Jersey. For news releases, webcasts and other information about
Datascope, please visit Datascope's website, http://www.datascope.com.

For more information contact:
Ulf Grunander, CFO 
+46 (0) 15 55 00